OGI

GeoLogic23

I am a fan of the Charlotte's Web, Organigram, British American Tobacco group of companies, in terms of relatively safe ways to be exposed to the hemp industry. I think all the LPs are, or will be, hemp plays to some degree. Tilray and OGI are both talking about it. Tilray has their hemp foods and wants to do beverages, while OGI has the CWEB connection via BAT, and OGI invested in Open Book Extracts, who do hemp products. High Tide and VFF both have CBD investments. Cronos and Aurora technically pulled out of the US CBD market a while ago, but Cronos never stopped lobbying for CBD, so I expect them to be back. InterCure in Israel is a favorite of mine as well. Mostly medical cannabis at the moment, but they have a deal with Charlotte's Web to distribute their products once CBD regulations change in Israel. This should have already happened but the war delayed it. Given that InterCure also has a supply deal with OGI, I see this as a partnership that will continue into the future. Could be good entry into the EU as well. Jones Soda and Flora Growth are both into hemp/CBD, but are both connected to very sketchy insiders (SOL Global crew), so there are significant risks in that regard. Lexaria Biosciences is doing research for CBD drugs and they license their CBD tech, so I follow them. Better Choice Company is a pet company that's long been associated with cannabis insiders. I'm watching to see them get back into CBD. Lifted Partners is a hemp products company I've been watching after finding out GTI licenses their brands to them. Flow Beverages is a beverage manufacturer I'm watching to get back into CBD. They have connections to Tilray/OGI/BioSteel, and they were originally going to make Gwynyth Paltrow/HEXO's CBD drink back in 2019. Synbiotic in Germany seems to be the most hemp focused of the German companies. They are also an investment by Bruce Linton, who has been very focused on hemp since leaving Canopy. He had a SPAC that was pursuing industrial hemp products, then he invested in Synbiotic, and earlier this year he joined the advisory board of a hemp cigarette company preparing to IPO. There's a few other random penny stocks. Long story short is that there aren't a lot of non-penny stocks that give you good exposure to the hemp industry, because that industry has been crushed so hard.

DEASqueezeAllComing

MSOS +8.17% OGI + 7.59% ACB + 7.56% VFF + 3.15% CGC + 2.37% TLRY + 1.09% Surprised to not receive more love on a 3.59% day for IWM.

GeoLogic23

If I had to bet I'd say something hemp/CBD related. Timing makes sense, and fits with moves other LPs like Tilray/OGI are doing. Also makes more sense for Texas.

theduderino38

TLRY MSOS OGI GTBIF all day!!

FoodCooker62

There's a pretty good chance this action is caused by CGC themselves selling shares on the open market. I know you hold a lot of stake in this company, but be mindful that the company is actually still on the expensive side, especially for how absolutely abysmally it is run. If it was valued like OGI or VFF in terms of EV/sales multiple it would be around $2, and those companies have much more streamlined operations.

KAESLAX

It's actually not that bad anymore. In the last year or two most of them have written off a lot of their intangibles. TLRY is the only one that's still really bad. Here are the numbers (% of total assets): - TLRY = 2.94B (70%) \*as of Q3 - CRON = 21 M (2%) - CGC = 109 M (11%) - SNDL = 146 M (13%) - ACB = 62 M (10%) - OGI = 8 M (4%) - VFF = 88 M (19%)

GeoLogic23

I am liking their moves lately. One thing I find interesting is how OGI has just started doing follow up investments with companies that BAT previously invested in. 9/15/22 - BAT invests in Open Book Extracts 9/26/22 - BAT invests in Sanity Group *11/6/23 - BAT invests in Organigram* 3/26/24 - Organigram invests in Open Book Extracts 6/25/24 - Organigram invests in Sanity Group I'd have to double check, but I think it was August when the next tranche of investment was coming from BAT to OGI. Two other prominent companies that would fit this pattern of investment are Charlotte's Web and Trait Biosciences.

Turbul

$OGI market cap is too low

oneMorbierfortheroad

I had 7 of the CHWY calls but sold 6 because....dumb. my other options are all at .01 and there are many. All CRON January WAY otms ($5, $5.50, and $7, premiums paid .03 for the 7 and .05 for the 5s... and not looking good. Failed to sell them when they mooned because I was sure they would continue mooning. Bad move. Anyway, once chwy popped, I had the first liquidity I have seen in a while. After that, I started juggling 0D spy calls and puts. Past few days were very good for it. Psychologically speaking, I feel like CRON tought me something I needed to learn: pot stocks suck, especially CRON and OGI for retail trading. They are technically the best-run and best balance sheets etc., but just not volatile and definitely not bullish until next catalyst. I bought the CRON calls because I have successfully flipped .05 and unders for .08 or .10 or more on pumps. But the real reasoh I bought so many junk contracts and am holding is that I once left about $60,000 dollars on the table on a $300 dollar pile of HMHC $7c when HMHC was at 4 dollars per share. I sold when those contracts went from .01 to .05 and took a very small profit after months of holding. Well, over the next few months, HMHC went private at $20 per share. So I tried to repeat that, but HMHC..... CRON is not. But I held one!

GeoLogic23

I am hoping they announce some kind of beverage play soon. I have been following Flow Beverages for a while, as they have BioSteel, OGI, and HEXO connections, and were doing CBD beverages back in 2019. Flow also has a connection (Ronan Levy) to the water soluble CBD tech company Trait Biosciences, who are funded by BAT and Gotham Green Partners. CWEB claimed they were going to release CBD drinks in late 2022. At the time this was also when Trait was supposed to be releasing their tech. Last news from Trait I heard the release was moved back and supposed to be Q1 2024. I noticed that at the same time CWEB went up like 50% on 500k volume earlier today that almost simultaneously Flow also had a really big jump on much higher volume than is typical for them. Just hypothesizing based on stock movement and connections. Don't invest in penny stocks based on this please. https://www.prnewswire.com/news-releases/trait-biosciences-closes-on-financing-led-by-bats-btomorrow-ventures-and-gotham-green-partners-and-advances-commercialization-of-unique-water-soluble-cannabinoids-301953852.html "The financing will support Trait's partnerships with contract manufacturers and go-to-market partners, and Trait expects a 1Q 2024 launch of its first-generation water-soluble CBD."

GeoLogic23

That's when she assumed the role officially. She was announced on [August 4th](https://www.sec.gov/Archives/edgar/data/1620737/000115752321000994/a52471368_ex991.htm). *"August 4, 2021--Organigram Holdings Inc......is pleased to announce Beena Goldenberg, formerly Chief Executive Officer of The Supreme Cannabis Company Inc. and previously Chief Executive Officer at Hain-Celestial Canada, ULC, has been appointed the Company’s new Chief Executive Officer (CEO). Ms. Goldenberg will assume the role effective September 9, 2021."* I don't think anybody ever said they weren't close with each other. Beena took over OGI knowing she was going to work with British American Tobacco. I like OGI, but I don't trust the tobacco industry. Everything they touch should be scrutinized as much as possible.

AmiaCalva7

I love that he includes the market share data for the other brands as well. Motif Labs and Weed Me are doing awesome as private companies. As someone who owns Rubicon, Cannara, OGI and VFF this is pretty much the most useful report.

mfairview

As per Hifyre, the top 5 players in May (1-mo) were Tilray 10%, Village Farms 8.6%, OGI 6.5%, Decibel 5.7%, and Cronos 5.1%. There were five more players between 2-5%, in order: Auxly, Motif, Cannara Biotech, Canopy Growth, and Weed Me. During the Mar-May period (when the market grew 8.6% yoy, as per Hifyre), Tilray sales fell 17% yoy; Village Farms grew 41%; OGI +24%; Decibel -12%; Cronos +34%. Re the top 5, if we look at 3-month total rec market share trends, in the May qtr (Mar-May), • Tilray had 10.3% share vs. 11.1% in 1Q24, 12.1% in 4Q23, and 13.6% in 1Q23 • Village Farms had 8.6% share in the May qtr vs. 8.1% in 1Q24, 6.8% in 4Q23, and 7.2% in 1Q23. • OGI had 6.9% in the May qtr vs. 7.3% in 1Q24, 6.8% in 4Q23 and 6.5% in 1Q23. • Decibel had 5.7% in the May qtr vs. 6% in 1Q24, 6.7% in 4Q23, and 6.6% in 1Q23. • Cronos had 5.3% in the May qtr vs. 5.4% in 1Q24, 5% in 4Q23, and 4.5% in 1Q23

GeoLogic23

David Culver of the US Cannabis Council talked about hemp beverages. He basically just talked about regulating them with age limits and stuff, not criminalizing them. This makes sense, as Curaleaf is the top player at the USCC. The most interesting comment that caught my eye though. [Skip to 3:00 in the video](https://www.cheddar.com/media/thc-infused-drinks-stir-up-high-hopes-and-higher-legal-scrutiny/): "**There is a piece of legislation that I believe will materialize in the US Senate relatively soon that is going to point towards the Food and Drug Administration as the primary regulator**" So there is some legislation coming soon to regulate hemp-derived beverages. And it's coming from the Senate, which I would interpret as a good sign. Also a reminder that David Culver is an advisor to [KEY Investment Partners](https://keyinvestmentpartners.com/advisory-board/). They are the primary investors in the hemp-derived products company Open Book Extracts that is an OGI/BAT investment.

WRONG_PREDICTION

OGI: Oh gee I lost all my gains

martyd94

What happened to OGI? Lol

FoodCooker62

If CGC was valued at OGI's ev/sales multiple, which would already make no sense as OGI has better margins, is better capitalized and actually has shown revenue growth since 2020, it would be $2.  A $250m dilution like they announced today would not even be possible.  But instead it maintains a gargantuan market valuation premium over its peers. And as such they can just spawn another quarter billion dollars to burn. And our sector remains uninvestable and a joke because of this state of affairs.

CannaVestments

Some highlights: 1) Growth is slowing: Q1 2024 sales were only up 2% yoy, down from 11% growth yoy in Q4, 14% for 2023, 17% for 2022. Hyfyre data suggests April/May were better though. 2) Per-capita sales is $105USD, well short of the $200+ we see in most mature US states. 3) "The top 5 players in May (1-mo) were Tilray 10%, Village Farms 8.6%, OGI 6.58%, Decibel 5.7%, and Cronos 5.1%. There were five more players between 2-5%, in order: Auxly, Motif, Cannara Biotech, Canopy Growth, and Weed Me." 4) Total Market share progression of top 5: -Tilray: Q1 2022: 17.6% Q1 2023 13.6% Q1 2024: 11.1% -VFF: Q1 2022: 6.5% Q1 2023 7.2% Q1 2024: 8.1% -OGI: Q1 2022: 7.2% Q1 2023 7.8% Q1 2024: 7.2% -Decibel: Q1 2022: 3.7% Q1 2023 4.3% Q1 2024: 5.3% -CRON: Q1 2022: 4.0% Q1 2023 3.9% Q1 2024: 3.7% 5) Segment leaders extended their respective leads. "When comparing 1Q22 with 1Q24, the three segment leaders posted impressive share gains: Village Farms from 10% to 16% in flower; Decibel from 5% to 14% in pre-rolls; Motif from 3% to 20% in vape."

No_Love_Gained

I am waiting for that to change to HITI and OGI.

martyd94

I've bought OGI recently too. I think they have good products and a cleaner balance sheet compared to most other LPs. I'm heavy into CL also.

JohnnySquesh

I'm continuing to buy MSOS. Starting to look at adding to my Green Thumb and Verano. All the names I like are top 5 holdings of MSOS, however, so I don't mind playing that for now. I do trade MSOS as well. I can justify owning these names without any action other than state by state rollouts. Political action is just a bonus. Slowly adding to Cronos and OGI on the LP side as well.

martyd94

I guess so. I bought some more OGI

Many_Easy

I’ve also been looking at some of the U.S. companies that were “approved” by DEA to supply medical cannabis for **research** in the U.S. There’s a few in South Florida and they are both very early stages and seem shady. I’d rather invest in companies like OGI supplying international.

Hey_Hank

Spreading out the export client base would help cushion the effect of export deals gone bad such as OGI's one deal in Israel. The one good thing about the Canadian retail system of provincial government wholesale distribution is that you know you will get paid.

Many_Easy

The value of 500 kg using a mid-range price of $2,500 per kilogram could be worth around $1.25 million per year for years 1-2 and a little more in year 3. So total deal worth about $4.0 million in revenues. As a small OGI shareholder, I want to see bigger deals in the pipeline.

GeoLogic23

OGI signed a supply deal with a 2nd UK company https://www.businesswire.com/news/home/20240528337587/en/Organigram-Signs-Three-Year-Supply-Agreement-with-Avida-Medical-in-UK

JohnnySquesh

Yes. I bought more MSOS and a bit of OGI, CRON

GeoLogic23

Organigram would have to be on that list, right? They are actively talking about hemp beverages, have zero debt and have investment money ready, etc They have investment/connections in hemp extracts and products (Open Book), CBD beverage tech (Trait Biosciences), hemp biomass/CBD (Charlotte's Web), and seeds/THCV (Phylos), as well a board member on Flow Beverages. BAT has also invested in multiple health/wellness beverage brands via Btomorrow Ventures. Seems like if you wanted to bet on hemp edibles/beverages, OGI would be a relatively low risk bet. At least compared to Curaleaf. (Also GTI had a Cann investment)

GeoLogic23

They already bought the beverage companies. We just established that. They just add Delta 9 now. *Listen*, you clearly despise Tilray for some reason. I'm just pointing out that the low dose hemp THC market is currently a federally legal market that is accessible to LPs. I'm not arguing for Tilray as a company, or for Irwin Simon as a CEO. I'm simply explaining their strategy. I'm primarily an OGI investor in Canada.

GeoLogic23

Funny that Lexaria was mentioned today, as they are actively working on CBD as a diabetes and/or weight loss control drug. https://lexariabioscience.com/technology/#commercial-applications You also have THCV that is being used a lot more recently. It supposedly acts as an appetite suppressor at low doses. The BAT/OGI investment in Phylos has been producing THCV products. https://www.marijuanamoment.net/thcv-increases-energy-and-motivation-without-marijuanas-munchies-effect-double-blind-study-finds/

hambone_83

In my opinion your points are your speculation as Tilray has not made these comments. You are transferring what OGI said to Tilray - If they did say it and I missed it then I apologize but I only hear Irwin saying whiskey infused with THC and stuff like that. Not low dose hemp beverages

GeoLogic23

Idk why you're ignoring my points. I explained this already. Schedule 3 announcement changed several things: They needed Delta 8 clarified. **This has explicitly been stated as a reason Canadian companies have stayed out of the US**. Go listen to OGI interviews from early 2023. They needed to know that schedule 3 wasn't changing anything about what is considered hemp. Now we know "low dose" products are staying as legal products. They needed their distributors to know these same 2 things. Hemp is federally legal. If you're only selling low dose hemp edibles or beverages you aren't even considered "plant touching" in the way we use the term.

GeoLogic23

As I said they needed the rescheduling announcement to clarify the status of Delta 8 and to confirm nothing was changing with how the DEA treated hemp derived Delta 9 coming from a <0.3% source. OGI has been saying since early 2023 that they were eyeing CBD as a US entry point but they could not do anything until the Delta 8 issue was cleared up. Also it's not just Tilray's decision. They need their distributors comfortable with the product. Now after the S3 announcement their distributors know the DEA is not going to consider <0.3% THC to be an issue. I imagine more and more distributors are going to feel comfortable carrying hemp derived beverages in the coming months.

JamesAll91

Why not OGI? Much lower take out target by another big tobacco (British American Tobacco) with a much more viable business. Seems like a more logical take out target (the other 45% by BTI). Keep in mind they bought the other trqches at $3.2 so OGI is at a good price to be taken out at a low valuation in their eyes with a lot of risk removing from the US market, which OGI is investing in for them.

GeoLogic23

I just want to see if they follow OGI and go after hemp assets in the US. Would be the obvious move, given their beverage focus and recent statements. "The Company currently intends to use the net proceeds from the ATM Program, if any, to fund strategic and accretive acquisitions or investments in businesses, including potential acquisitions of assets in the U.S. and internationally in order to capitalize on expected regulatory advancements or expansion opportunities. **The Company does not currently intend to use the net proceeds from the ATM Program for general working capital purposes.**" So sounds like this is straight up acquisition money. I personally hope that Tilray fulfills the old prophecy and finally buys Jones Soda.

GunBrothersGaming

Im still down $4k on SNDL and OGI cause the last time this happened

GeoLogic23

It takes a decent bit of biomass, but that's what they are doing. Some states have outlawed this, or are trying to regulate hemp products like other cannabis products. These tend to be states with a more developed cannabis market. Red States seem to be fine with hemp products for the most part, even though it's extremely hypocritical to their stances on med/rec cannabis (see post about Texas below). But yes right now many companies are shipping hemp products around the country, with minimal regulations, and they don't have to deal with 280e. It's a booming industry, with many top players either releasing hemp derived edible/beverage products, or talking openly about entering that space (Tilray and OGI both recently).

GeoLogic23

TLDR: Besides being the largest Israel company, they have solid financials with growth potential domestically and internationally. I think they are a sneaky good EU play. They also fit extremely nicely into my focus on CBD, having CWEB/OGI partnerships and Israel being set to expand CBD. I kept trying to summarize financials briefly, but it's a bit complicated. Their last one was for 2nd half of 2023, right when the war started, and their main facility was in the attack zone. They're entitled by law to get reimbursed for any damages, and they've started receiving that, but a brief summary of recent numbers would be misleading. Best to look at [1st half 2023](https://www.intercure.co/news-releases/news-release-details/intercure-announces-record-revenues-first-half-2023-over-14) for a better sense of how they'll look moving forward. In their more [recent release](https://www.businesswire.com/news/home/20240430357217/en/InterCure-Announces-FY2023-Results-Revenue-of-NIS-356-million-and-Adjusted-EBITDA-of-NIS-61-million) their revenue was heavily impacted by war starting. They were projecting sequential double digit growth in 2024 though, so hopefully back to full strength now. Other general financial stuff: Positive cash from operations recently and positive EBITDA for a long time. Nothing looks crazy with their assets/liabilities to me. Goodwill could be lower. High insider ownership (43% - 8 people). Market cap is still just $150M, which I think is <1x yearly revenue if they're back to normal. When comparing scale of business, consider that Israel is less than half of a Florida in population. InterCure is the largest Israel company. Idk I don't see any major red flags financially (let me know if you do), but it is complicated because of recent events. It's the growth story I'm most interested in, as I think they should "win" the Israel market and they also have strong international ambitions and partners. [Israel just expanded medical cannabis access in April](https://www.nasdaq.com/press-release/imc-applauds-the-april-1st-implementation-of-the-new-israeli-cannabis-regulation). Combine that with the [sharp rise in cannabis prescriptions already reported in November](https://www.marijuanamoment.net/medical-marijuana-prescriptions-rise-sharply-in-israel-amid-war-with-hamas-government-says-as-patients-seek-relief-from-ptsd-and-pain/), and I can see some solid growth quarters coming. InterCure has been acquiring their [own cannabis pharmacies too](https://www.intercure.co/news-releases/news-release-details/intercure-signs-definitive-agreement-acquire-leon-cannabis). InterCure's international partnerships are very interesting: Organigram / Charlotte's Web / Tilray / Cookies / TYSON 2.0 / Binkse (among others) InterCure should be expanding into Germany soon. They are partnered with Cookies for retail stores in Austria and the UK. They are the exclusive partner for TYSON in Germany/UK/Israel/Australia. As a big Organigram and Charlotte's Web guy, I am also closely watching the expansion of CBD in Israel. A couple years ago they said they were finally [removing CBD from the dangerous drug ordinance](https://hemptoday.net/israel-moves-to-normalize-cbd-2-year-path-to-market-expected/). This would greatly expand the CBD market in Israel, which is more restricted than you would think given their long history with cannabis. Removal from the DDO would finally allow CBD sold over the counter and in cosmetic and food products. It's already supposed to have happened in February 2024. In InterCure's financials they say: *"In August 2023, the IMCA published......the report refers to the current regulatory status of CBD,* ***providing timelines for the removal of CBD from the DDO in February 2024****.* ***However, this has yet to have occurred****."* InterCure's agreement with Charlotte's Web doesn't actually kick in until CBD is removed from the DDO. InterCure already has a partnership established to distribute CWEB products via Altman Health: *"In March 2022, we announced a strategic partnership with Altman Health.....1,700 points of sale, including all major pharmacies.....Intercure and Altman Health plan to register, market and distribute Charlotte’s Web branded products in Israel.....marks a significant milestone for the company’s CBD expansion strategy, the joint venture has not been established yet due to current CBD regulations in Israel. CBD is still classified as a controlled substance in Israel and meaningful operations are not allowed until it is delisted."*

Throwing_Horns

^(That BNN Bloomberg article from May 2021 before Goldenberg was with OGI.)

GeoLogic23

Reposting from the daily because it's more relevant here: Was just reading OGI's earning's call. A few things just regarding strategy to note. **They talk multiple times about the hemp-derived beverage and edible space. When talking about Open Book Extracts:** *"Through this investment, Organigram stands to gain invaluable insights into the U.S. landscape by leveraging OBX's extensive experience with key players in the U.S. cannabis market."* * OBX has lots of Acreage/Canopy connections *"Moving forward, we expect to collaborate with OBX on product launches in the U.S., capitalizing on the explosive growth of the hemp-derived THC market for edibles and beverages."* **They also talk about the new nano-emulsion technology they are working on:** *"You've heard me speak about the nano-emulsion technology that is being worked on....the patent-pending nano-emulsion technology aims to unlock...."* *"The nano-emulsion production equipment was recently transported to Organigram's Winnipeg facility in April, and the company is preparing to scale up production and sales for these gummies in the fall."* * I think this is the CBD tech I've talked a lot about recently, being launched by [Trait Biosciences](https://traitbio.com/distilled/). They are another of BAT's investments, like Open Book Extracts. * OGI has a 50% market share of CBD gummies, so this makes sense **Later on in questions, more hemp-derived and emulsion discussion:** “….we're very excited about the hemp-derived THC market for ingestibles, for both beverages and for edibles.” “What excites us about this is the direct-to-consumer opportunities that you could move products across state lines.” “We see the opportunity of using the nano-emulsion technology that we're developing in some of the products that we take to the market in the U.S. at some point in the future.” **Regarding distribution in the US:** “So nothing in the short-term in terms of using the BAT distribution network, we'd be looking at how OBX is getting products out. We'd be looking at other partners that we could leverage.” * I feel like OGI might partner with Tilray for distribution. They have multiple strong connections including Beena/Irwin and Tilray/CWEB deal. * Tilray has also talked recently about the potential of the hemp-derived market * I had a theory that everybody was going to [use Southern Glazer's](https://www.reddit.com/r/weedstocks/comments/1cnqzkm/comment/l3dbze3/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) for distribution in late 2022, but I think Southern Glazer's had some issues. Canopy was also signed with Southern Glazers early on. * One of the top things Tilray highlighted with their AB InBev purchase was [access to their distribution channel](https://tilray.gcs-web.com/news-releases/news-release-details/tilray-brands-announces-agreement-acquire-eight-beer-beverage).

GeoLogic23

Was just reading OGI's earning's call. A few things just regarding strategy to note. **They talk multiple times about the hemp-derived beverage and edible space. When talking about Open Book Extracts:** *"Through this investment, Organigram stands to gain invaluable insights into the U.S. landscape by leveraging OBX's extensive experience with key players in the U.S. cannabis market."* * OBX has lots of Acreage/Canopy connections *"Moving forward, we expect to collaborate with OBX on product launches in the U.S., capitalizing on the explosive growth of the hemp-derived THC market for edibles and beverages."* **They also talk about the new nano-emulsion technology they are working on:** *"You've heard me speak about the nano-emulsion technology that is being worked on....the patent-pending nano-emulsion technology aims to unlock...."* *"The nano-emulsion production equipment was recently transported to Organigram's Winnipeg facility in April, and the company is preparing to scale up production and sales for these gummies in the fall."* * I think this is the CBD tech I've talked a lot about recently, being launched by [Trait Biosciences](https://traitbio.com/distilled/). They are another of BAT's investments, like Open Book Extracts. * OGI has a 50% market share of CBD gummies, so this makes sense **Later on in questions, more hemp-derived and emulsion discussion:** “….we're very excited about the hemp-derived THC market for ingestibles, for both beverages and for edibles.” “What excites us about this is the direct-to-consumer opportunities that you could move products across state lines.” “We see the opportunity of using the nano-emulsion technology that we're developing in some of the products that we take to the market in the U.S. at some point in the future.” **Regarding distribution in the US:** “So nothing in the short-term in terms of using the BAT distribution network, we'd be looking at how OBX is getting products out. We'd be looking at other partners that we could leverage.” * I feel like OGI might partner with Tilray for distribution. They have multiple strong connections including Beena/Irwin and Tilray/CWEB deal. * Tilray has also talked recently about the potential of the hemp-derived market * I had a theory that everybody was going to [use Southern Glazer's](https://www.reddit.com/r/weedstocks/comments/1cnqzkm/comment/l3dbze3/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) for distribution in late 2022, but I think Southern Glazer's had some issues. Canopy was also signed with Southern Glazers early on. * One of the top things Tilray highlighted with their AB InBev purchase was [access to their distribution channel](https://tilray.gcs-web.com/news-releases/news-release-details/tilray-brands-announces-agreement-acquire-eight-beer-beverage).

Slacker_75

OGI is a fucking disaster behind the scenes, biggest known secret in New Brunswick.

GeoLogic23

I mean... They did? They own almost half the company lol Odd you'd call Beena useless. She's managing all the day to day and coordinating OGI's goals with BAT's. Seems like we disagree on a lot here and it probably isn't worth arguing over. Good luck out there.

slobjones11

Yes. I'm saying it's bad for OGI to exist as an independent LP if Been Goldenberg is going to exist as a useless cipher. If BAT wants to run OGI, BAT should buy OGI.

GeoLogic23

? I have no idea what criticism you are making here. I absolutely want the giant multinational CPG company guiding OGI to a place where they can synergize all their various hemp assets. Are you saying it's bad to have BAT calling the shots at the company? I couldn't disagree more if that's the case.

GeoLogic23

I disagree. I think it's a play for the upcoming Farm Bill and the potential expansion of hemp derived products in the US and around the globe. Some of BATs recent investments besides OGI are into: Charlotte's Web: US hemp Open Book Extracts: US hemp Trait Biosciences: US CBD emulsion tech Phylos: US seeds and genetics, including minor cannabinoids like THCV

slobjones11

OGI is turning into another CRON. Getting fat with tobacco cash and losing interest in the bottom line. At best, it's a long, long, long-term play.

slobjones11

Biological assets: OGI dumped a lot of excess pot -- either destroyed or sold off cheap. Derivative liabilities: The value of an investment fell -- or something like that. Bury investors in accounting terms and hope they don't ask questions. https://www.investopedia.com/terms/f/fairvalue.asp#:\~:text=The%20fair%20value%20of%20a%20derivative%20is%20determined%20by%20the,on%20the%20stock%20also%20increases.

slobjones11

Except for OGI and VFF, which are dumping.

Street_Village3606

I like Organigram listed on the NASDAQ and TSX symbol OGI. Top three cannabis company in Canada with international export prospects. Company reported their Q2 2024 ending March 31 this morning. Revenues were flat q/q at $37.5 million CAD due to a bad debt of $4.2 million to an Israeli importer (Canndoc). Company has the backing of British American Tobacco which has a 20% interest and is investing another $124.6 million CAD.. OGI will have $195 million CAD in cash pro forma the last of three $41.5 million CAD tranches of shares issuable to BAT at $3.22 CAD. Zero debt. Stock trading at $2.55 CAD or a 20.8% discount to what BAT is buying shares for.

TreeSmoka420Joka

Hey Geo! What are your thoughts on the latest OGI earnings report?

GeoLogic23

Yes the point that all cannabis is mostly THCa is one of the primary things I'm trying to explain to people. However most batches you get from MSOs are higher than 0.3%. Some are not. It's hard to consistently produce that. Just like hemp, if they test hot that crop would be a total loss and all get burned. I'm concerned that the seeds for strains that are legitimately stable, and able to consistently produce federally legal products, are currently being developed by big ag and big tobacco, etc.. BAT via OGI just invested in Phylos recently, and BAT is probably the largest company openly focused on hemp and CBD. CWEB (part of the BAT/OGI network) was the first to patent a hemp strain in 2019 with <0.3% THC. https://www.cannabisbusinesstimes.com/news/stanley-brothers-charlottes-web-cbd-hemp-plant-variety-patent/ "In 2014, one year after the debut of Weed, the Stanley brothers committed to keeping Charlotte’s Web beneath the 0.3-percent THC threshold—effectively developing it into a hemp cultivar." "In the public documents, Stanley described a plant type capable of producing 6.24-percent CBD content and 0.27-percent THC content." "And as we’re seeing with the 2019 harvest season, “hot” crops are a major problem in the industry. Crops that test above that 0.3-percent THC limit must be destroyed, according to most state statutes, and so one of the important educational trends in the business right now is to identify reliable hemp varieties that won’t leap past that threshold when it comes time to test and cut the crop. As the industry matures over these next few years, it may come to pass that clone stock becomes a more vital part of a grower’s arsenal"

Hey_Hank

I have some of the Organigram gummies that are THCV. Taste great. Work great like a regular gummy. But it seems my stock of bags of chips tend to survive much much longer. OGI and their partner BAT have a significant investment in Phylos.

phatbob198

Some upcoming earnings dates for *MSOs* :-- **PLTH**- May 13^th **CRLBF**- May 15^th **AYRWF**- May 15^th ^8:30am Some *LP* earnings (a few are estimates) :-- **OGI**- May 14^th ^8am **ACB**- May 29^th **CGC**- May 30^th **HITI**- ~June 12^th **TLRY**- ~July 24^th

JoelPolish

OGI. TIL. Several have big tobacco and alcohol buying in. With that push. They will get it done. Doesn’t matter who is in charge. Money is what will make it happen. Pockets have already been lined.

phatbob198

Here are some earnings dates for *MSOs* :-- **PLTH**- May 13^th **CRLBF**- May 15^th **AYRWF**- May 15^th ^8:30am Here are some *LP* earnings (a few are estimates) :-- **OGI**- May 14^th ^8am **ACB**- May 29^th **CGC**- May 30^th **HITI**- ~June 12^th **TLRY**- ~July 24^th

bananastock

I just charted the best performers since Aug 29 2023 the day before the original Bloomber S3 HHS leak. TRUL 149% CGC 98.51% CURA 70.93% CL 68.45% VRNO 59.52% GTII 51.73% ACB 38.21% OGI 15.03% TLRY -25.35%

bananastock

Managing their balance sheet responsibly and focused on return on equity. Cura went ham expanding and got a bunch of debt. TRUL made an aquisition that dragged them down for a while. CRESCO wasted a bunch of time on a failed merger. The others arent running profitable businesses. Ben and their team know and live by the values of great investors like Warren Buffet and Peter Lynch. GTII and TRUL are the only companies in the sector I have no concerns about on the US side and ACB and HITI and maybe OGI on the Canadian side. There may be other gems, I just dont know about them.

GeoLogic23

(Disclosure: I already had some, but bought a decent chunk of Flow Beverage Corp on the big dip today at all-time lows) I mentioned the other day how pretty much the whole BioSteel team appears to have moved to a new company called Cizzle Brands (started by BioSteel co-founder). It appears they have a BioSteel clone coming out soon called Cwench Hydration. I mentioned that besides it being a bunch of the BioSteel team, the Cwench beverage looks the same as BioSteel. If you look at the flavors, you can see that they are almost certainly going to be manufactured through Flow Beverages. It's the same packages and flavor profiles: **BioSteel / Cwench** Rainbow Twist / Rainbow Swirl Blue Raspberry / Blue Raspberry Cherry Lime / Cherry Lime Mixed Berry / Berry Crush Flow Beverages was also the manufacturer for both Flow Glow (HEXO's CBD drink) and BioSteel, which was supposed to be a CBD drink when Canopy bought them. If you look at the re-organization documents from BioSteel you can see Flow and Cizzle Brands tried to buy BioSteel in late 2023, but they didn't have the winning offer. One of the only non-BioSteel employees of Cizzle Brands is Ronan Levy, a longtime board member from the water soluble CBD tech company Trait Biosciences. Cwench has said they are releasing their beverage in "Spring 2024" while Trait is supposed to have already released their CBD tech, as they claimed "Q1 of 2024" at the end of last year. So I feel pretty confident that Flow will be adding Cwench products to their manufacturing, but I also think Cwench is going to be a CBD hydration brand. (Also Trait is funded by BAT, and a member of OGI joined Flow Beverage board in late 2022)

GeoLogic23

One thing I find interesting is that One Hemp terminated their lobbying registration with their only lobbyist on 3/31/24. That lobbyist was David Culver, formerly of Canopy Growth, and whose only client now is the US Cannabis Council First Culver registered with both the US Cannabis Council and Open Book Extracts (BAT/OGI investment) Then he terminated with Open Book Extracts less than 6 months later, and immediately registered with One Hemp (clearly following Open Book Extracts, as they had just helped form One Hemp). Now Culver has terminated with One Hemp after only 3 months, but he has actually joined the advisory board of the primary investors behind Open Book Extracts ([KEY Investment Partners](https://keyinvestmentpartners.com/advisory-board/)). Besides David Culver, who led Canopy's entry into the US as a CBD company, KEY's advisory board also has Canopy Growth's old head of their US THC Strategy. That person's bio says they are currently CEO of a start-up cannabis company that is operating in stealth mode.

4Inv2est0

What investment did they receive from BAT? Interesting considering OGI+BAT and their success with CBD gummies in Canada

phatbob198

Hey Geo, I think it may have been you who told me about OGI having their earnings moved before. Just letting you know in case you didn't see yet, I updated their date cause it is apparently May 14th at 8am now. https://www.businesswire.com/news/home/20240508446271/en/Organigram-to-Report-Second-Quarter-Fiscal-2024-Results-on-May-14-2024

theduderino38

I’m all in on a lot of shares, MSOs and LPs and ETFs mostly MSOs and MSOx Greenthumb, Truelive, Curaleaf, Cresco CCG Tilray Ascend Verano planet13 Cannabist Sundial OGI are my top picks Good luck to all (longs) to the moon!!! 🌕

GeoLogic23

lol keep having to go back to CGC. I bet you haven't even looked into other LPs in a long time. You are completely tunnel visioned. Several LPs including OGI/CRON have no debt due to significant investment by major partners. OGI is receiving active investment which is going towards the US hemp market right now. You're missing my entire point still. I explicitly discussed why they had so much debt. They were forced to dilute to get rid of their debt. Now that they don't have debt, they are far more attractive as investments. Both for retail and for big partners. Like I didn't throw money at ACB when they were actively paying off their debt, with no catalysts on the horizon. But I invested with them when they finished paying it off and reverse split, conveniently becoming debt free and in compliance right before all the expected catalysts I've been discussing are occurring. Now they are basically debt free with plenty of cash to make it through Germany rollout, Schedule 3, and The Farm Bill. **Again please stop insulting LP holders. Why do you have to keep doing that?** I have an extremely nuanced view of the global cannabis sector. Many of us do. Just because you're unwilling to entertain any other opinion, you portray us as Charlie. And most LP holders (including myself) have investments in the US as well. Go read the article on today's daily discussion regarding hemp products. If you won't listen to me maybe you'll listen to Forbes.

GeoLogic23

I already did that lol I asked you about your thoughts on all the LPs and insiders focusing on CBD and hemp derived Delta 9, which are both federally legal products. You ignored that question, as well as the other similar question someone asked. Do you have thoughts on Tilray, OGI, Cronos, Curaleaf, Jones Soda, Snoop Dogg, W. Brett Wilson (GreenAcre Capital), Bruce Linton (Synbiotic) and many others all having strong interest in hemp derived products recently? Have you been following the strong recent growth in hemp derived cannabis beverages, such as Cann? They have major investors including celebrities like Gwyneth Paltrow, and cannabis companies like GTI. One of the other investors in Cann is Artemis Growth. This is the investment firm run by the guy who partners with Curaleaf's Boris Jordan at Bloomwell Group. Artemis has quite a few other hemp cannabinoids investments too. They are also GTI investors. The GTI / Circle K connection is ideal for help beverages as well. Artemis Growth just this month merged with Tenacious Labs. This is a 100% CBD focused company run by a member of the Bacardi family (Adrian Clarke). Part of their business is white labelling CBD seltzers. The recently promoted head of Global Growth at Bacardi has also been on the advisory board for Trait Biosciences for many years. Trait is focused on water soluble CBD that is not a nano-emulsion. Trait is funded by Gotham Green and British American Tobacco. They have said they are set to finally commercialize their product after 7 years of development. I'm just saying if you had been around in 2018 you know beverages have always been a primary goal of Canadian companies. Right now looks like the best setup ever to finally realize that vision. I think the activities of insiders and private equity also supports that idea.

GeoLogic23

Barely anybody who discusses this is saying Canadian companies are buying the big MSOs. Idk why people keep having to frame it this way. People keep complaining about those investing in LPs, while literally just ignoring every logical reason that is given for doing so. We are all saying they would buy/partner with smaller, medical only companies. Like tier 3, or more likely a private company. There are many states that don't even have MSO presence. There is plenty of the US up for grabs for everybody. Do you have any opinion on using federally legal Delta 9 and CBD to sell nationwide beverages? LPs have had their sights on beverages since 2018, and recently hemp derived beverages are growing very fast. Tilray is talking about it as their plan. OGI is investing in hemp extraction. Gotham Green is investing in water soluble CBD tech. Jones Soda switched to hemp D9 drinks and D9 gummies. Snoop just released a hemp D9 drink, his Tsumo snacks switched to hemp, and his Dogg lb gummies are only hemp D9. Just take a state like Texas. Very big into hemp, and very restrictive of cannabis. Don't you think there's a small chance that LPs actually gain the better foothold in Texas? Snoop even partnered with a Texas company for his beverages.

phatbob198

And here are some of the next LP earnings (some may be estimates): VFF - May 8th. CRON - May 9th. SNDL - May 9th. ACB - May 29th. CGC - May 30th. TLRY - July 24th. OGI - T.B.D.

tstrand1204

LPs since S3 announcement: CGC +27% | SNDL +20% | TLRY +18% | OGI +4% | VFF 0% Doesn't really make sense

FoodCooker62

Are they dead tickers walking if they just keep getting money handed to them by a market with endless gambling appetite? It is difficult to believe but Canopy is trading at a 6x higher valuation than OGI and VFF which are hovering in the neighborhood of break-even margins despite running a cash furnace. 

No_Love_Gained

OGI - Where art, thou?

No_Love_Gained

OGI

No_Love_Gained

OGI wants to have a word!

ancienci

**Total Shorts Market Value (all cannabis stocks):** 🇺🇸 US Markets: $655,747,652 USD 🇺🇸 ETFs: $208,242,442 USD 🇨🇦 Canada: $69,188,933 USD 🌎 TOTAL: $933,179,027 USD **🚨 Most Shorted Stocks (% of Float):** 18.53% – $MSOS – $192,916,536 17.32% – $ACB – $59,172,239 16.42% – $TLRY – $225,243,571 12.99% – $CGC – $82,562,595 7.77% – $HITI – $12,408,148 7.65% – $IIPR – $205,605,732 7.36% – $GRWG – $9,630,699 4.42% – $OGI – $8,566,669 4.42% – $FLGC – $1,024,969 4.39% – $SNDL – $22,071,011 src: [https://twitter.com/WeedStreet420/status/1785052800075841933](https://twitter.com/WeedStreet420/status/1785052800075841933)

ancienci

There is definitely a potential for a squeeze: **Most Shorted Stocks (% of Float):** 18.53% – [$MSOS](https://twitter.com/search?q=%24MSOS&src=cashtag_click) – $192,916,536 17.32% – [$ACB](https://twitter.com/search?q=%24ACB&src=cashtag_click) – $59,172,239 16.42% – [$TLRY](https://twitter.com/search?q=%24TLRY&src=cashtag_click) – $225,243,571 12.99% – [$CGC](https://twitter.com/search?q=%24CGC&src=cashtag_click) – $82,562,595 7.77% – [$HITI](https://twitter.com/search?q=%24HITI&src=cashtag_click) – $12,408,148 7.65% – [$IIPR](https://twitter.com/search?q=%24IIPR&src=cashtag_click) – $205,605,732 7.36% – [$GRWG](https://twitter.com/search?q=%24GRWG&src=cashtag_click) – $9,630,699 4.42% – [$OGI](https://twitter.com/search?q=%24OGI&src=cashtag_click) – $8,566,669 4.42% – [$FLGC](https://twitter.com/search?q=%24FLGC&src=cashtag_click) – $1,024,969 4.39% – [$SNDL](https://twitter.com/search?q=%24SNDL&src=cashtag_click) – $22,071,011 src: [https://twitter.com/WeedStreet420/status/1785052800075841933](https://twitter.com/WeedStreet420/status/1785052800075841933)

theduderino38

HODL a lot of YOLO MSOS and calls longs on TLRY OGI ACB GTI and a bunch of others!!

TSX-EUROSUNMINING

$OGI also

TSX-EUROSUNMINING

$OGI up 10% on this U.S. Drug Enforcement Administration may reclassify marijuana as a less dangerous drug.

NaturallyZen

Adding OGI as a laggard

slobjones11

OGI wins. Or neither.

4Inv2est0

TLRY vs OGI .... Who wins? I'm only asking the bagholders so all answers are bias.

GeoLogic23

OGI had a shift in their fiscal year recently that I think messed up some earning date estimates. They just released their last earnings on February 13th, and pretty sure they haven't announced their next release date yet. Also SNDL announced theirs for May 9th

phatbob198

Since someone already asked for MSOS earnings dates, I figured I'd also post some LP earnings (some may be estimates): OGI - April 29th. VFF - May 8th. CRON - May 9th. SNDL - May 13th. ACB - May 29th. CGC - May 30th.

FoodCooker62

I think you're looking at the wrong angle. 2 of the liquid LPs have underperformed in this rally: OGI (which diluted) and TLRY (which had dubious earnings). CGC and ACB dont have earnings for quite a while so there's nothing currently to shatter the illusion. 

GeoLogic23

BAT's most recent investment via their Btomorrow Ventures was in a bioplastics company called FlexSea. BAT's largest shareholder is Kenneth Dart, who lives in the Caymans now. Besides his vulture fund he most associated with Michigan and the Dart Container Corporation. They make tons of foam and plastic containers, including Solo Cups. [https://en.wikipedia.org/wiki/Dart\_Container](https://en.wikipedia.org/wiki/Dart_Container) BAT has multiple connections to Ohio as well. Of course there is John Boehner (also with Acreage Holdings) BAT/OGI also just invested in hemp company Open Book Extracts, whose founders are from Ohio and originally started a cannabis company in Ohio that was bought by Acreage.

GeoLogic23

OGI just invested in a hemp extract company. Obviously they already have the CWEB connection too. https://www.businesswire.com/news/home/20240326681362/en/Organigram-Invests-in-U.S.-Based-Open-Book-Extracts-Representing-Inaugural-Jupiter-Investment Tilray has talked about CBD and Delta 9 recently, saying they will have to be into it. Both CBD and D9 beverages make perfect sense given their legality, and ability to be sold nationwide. Jones Soda recently partnered with Tilray and just released Delta 9 beverages. Cann is the most popular cannabis beverage. It is hemp derived, and has long been associated with MedMen/HEXO. Snoop just released a Delta 9 beverage (Do It Fluid). ACB and CRON have shared minor cannabinoid biosynthesis IP together recently. Part of the final order on CBD, etc will be categorizing synthetically produced CBD the same as natural, as long as it's <0.1% THC. https://www.prnewswire.com/news-releases/aurora-and-22nd-century-group-license-foundational-biosynthesis-ip-to-cronos-group-301444681.html Might explain why both ACB and CRON both pulled out of their hemp derived CBD companies right after last year's DEA supply chain conference. This would also explain why CRON still lobbies mostly just for CBD in the US. https://lda.senate.gov/filings/public/filing/263e53bf-9401-4224-b740-2dd6acdcdbba/print/ You also have BAT and CRON (Btomorrow Ventures and Gotham Green) teaming up to fund Trait Biosciences. Trait has been working on water soluble cannabinoid tech since 2017. BAT and Gotham closed on financing for them in late 2023. They claimed they were ready to launch their product finally in the first quarter of 2024. This coincides perfectly with the expected final order on the 2018 Farm Bill that is currently supposed to be finished sometime in April (4/00/24). https://www.prnewswire.com/news-releases/trait-biosciences-closes-on-financing-led-by-bats-btomorrow-ventures-and-gotham-green-partners-and-advances-commercialization-of-unique-water-soluble-cannabinoids-301953852.html

DEASqueezeAllComing

TLRY could use some love from a big tobacco or alcohol without having them take a big stake a modest 10% minimum to spark the love back like the other LP : OGI + British American Tobacco CGC + Constellations Brands Cron + Altria

GeoLogic23

Looking back on it, OGI's dilution during the run up is looking pretty well timed

JoelPolish

Ya. They are more expensive. This is penny stock. Gambles with big opportunities. More like betting on a long shot or buying a lottery ticket. I have OGI. But it also is not a penny stock. But if you have $100 to throw away. This stock may blow up and make some money.

Saisinko

Aphria went to Tilray, which I view as American, which is designed to get bought up as a CPG company. CGC was designed to go to Constellation, although that relationship is questionable. However they split themselves into a US entity and I’m curious if they’ll reverse acquire themselves. Cronos is sitting on a fat stack of cash from Altria. Then factor in these LPs acquired other Canadian LPs like Mettrum, Medrelief, Broken Coast, Heidi and many others. Not many of the LPs in Canada are actually making money. Then if we want to be cheeky, the reality is many MSOs are registered in Canada for CSE stock purposes, those will swap to American eventually. So what stays Canadian is the real guess. ACB? Doubt it. Village Farms? Maybe. OGI? I’m surprised they haven’t been bought already.

Fergizzo

I'm selling my OGI because of this, and I want to sell my Tilray but I'm down too much.

SuzyCreamcheezies

Tilray as they have the most cannabis revs/marketshare. Followed by OGI and VFF, I'd guess.

pincandies

the ones with the smaller market caps like VFF OGI SNDL etc

JoelPolish

I am $60k deep on OGI. Never backing down 💎🤚🏻📈⬆️

JoelPolish

I am buying the dip on OGI. And then it double dipped. Now nobody wants it

LectureAgreeable923

It's cyclical two quarters ago they did Q1 70 million and have been organically growing year over year with cannibis.But certain quarters they make adjustments in SKU,s this is their quarter for that gearing up for summer and in the next two quarters you will see organic growth. VFF and OGI do the same thing and put out earnings where growth dips, yet overall, they show growth .Tilray has been growing year over year about 3 % plus.But in canada, how much do you really want to grow with a 30 to 35 percent excise tax .I look at tilray excise tax over 21,27 28 million paid over the last 3 quarters. If they change it, the push is on for tlry,vff ogi.You will see tilray starting posting their new line ups now, and by the time they get Q1 2025 2 quarters away they will be 75 million.Vff has their cyclical dips similar time too quarter ending March 31st 2023 their cannibis growth was down too . If you look at cyclical patterns their both very similar their some deviations, but overall they show year over year growth.

DEASqueezeAllComing

The purpose of a reverse split is to stay above 1$ so you don't lose your NASDAQ exchange listing. A company is forced to do that when their share is trading below 1$ for a specific amount of consecutive days. That's the only reason OGI, ACB and CGC made a reverse split

LectureAgreeable923

Yea, I get it tilray 1,village 2 decibel 3 ogi 4 .That's where it's you got to do the conversion from CAD to USD since Tlry and VFF post in USD.. I converted it .I like Tilry VFFand OGI .I don't see a big erosion in TLRY. The market overreacted their earnings, wasn't that bad .It's also seasonal.Lets hope excise tax comes in. Otherwise, there's not a big reason to expand when the government takes 30 to 35 percent. Tlry,s earnings wasn't that bad when you dive into it. They lost money to weather regarding distribution. The IT system went 8 million, which is usually very consistent it never changes, so I believe their guidance hurt them. The overreaction was that they only really pushed it out 1 quarter, which isn't that far away .The funny thing is that it is a good thing because right now canadian cannibis companies should not post good earnings .Why were you fighting for excise tax.Tlry put things in early written guidance that made it look worse, and they didn't have to .I believe they did for a reason excise tax .

Blistorious

There's a lot of downvoting in this sub lately. Must be some newer folks. The thing is tlry killed the momentum (again).. and generated a new generation of salty bagholders. Will there be a bounce back? OGI for example is still waiting.. and with tlry's outlook I don't know. Imo tax reduction/S3 is needed.

DEASqueezeAllComing

Observations for LP , do we have more juice if excise taxes recommendations are accepted and in effect on April 16th 2024 Canada Budget? |Ticker|All time low|2024 high|% move| |:-|:-|:-|:-| |CGC|2.76|11.57|+319%| |OGI|0.6512|2.91|+346%| |ACB|2.84|8.88|+212%| |TLRY|1.50|2.97|+96%| |VFF|0.5486|1.57|+186%|

GeoLogic23

OGI, CRON, and SNDL have had no debt for a while